Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516232 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
EnterprisewideAdd to Basket
Electronic (PDF)Add to Basket
Live Chat Live Help Software for Website

Omega Pharma NV - SWOT Analysis

Datamonitor, Feb 2011, Pages: 20


  Description  
   Table of Contents   
    
    
    
     
  Enquire before Buying   
  Send to a Friend   

The Omega Pharma NV - SWOT Analysis company profile is the essential source for top-level company data and information. Omega Pharma NV - SWOT Analysis examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

Omega Pharma (Omega) is engaged in the development, marketing and sales of over-the-counter (OTC) pharmaceuticals. The company provides cough and cold therapies; pain relief products; vitamins, minerals, and nutritional supplements; products against gastro-intestinal disorders; skin care products; anti-allergy products; and smoking cessation therapies. It also offers anti-mosquito products, slimming products, and home diagnostics. The company primarily operates in the Europe. It is headquartered in Nazareth, Belgium, and employed 1,945 people as of December 31, 2009. The company recorded revenues- of €822.8 million ($1,147.5 million--) during the financial year (FY) ended December 2009, an increase of 0.7% over FY2008. The operating profit of the company was €95.7 million ($133.4 million--) during FY2009, a decrease of 3% over FY2008. The net profit was €76.8 million ($107.1 million--) in FY2009, an increase of 41.6% over FY2008. - Revenues = turnover + other operating income. -- Calculated using a constant conversion rate of €1 = $1.39463 for the financial year ended December 31, 2009.

Scope of the Report

- Provides all the crucial information on Omega Pharma NV required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting Omega Pharma NV in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of Omega Pharma NV
-Data is supplemented with details on Omega Pharma NV history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from Omega Pharma NV

Reasons to Purchase

- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available



Customers who bought this item also bought

Omega Pharma NV - Strategy and SWOT Report

Heineken N.V. - SWOT Analysis

Ordina N.V.

Royal DSM N.V. - SWOT Analysis

Agfa-Gevaert N.V.

Telenet Group Holding NV - SWOT Analysis

CSM nv - SWOT Analysis

Wolters Kluwer nv - SWOT Analysis

VION N.V. - SWOT Analysis

Brookdale Senior Living, Inc. - SWOT Analysis



For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-800-526-8630 (US/Canada Toll Free)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds